Cobalamin Deficiency May Induce Astrosenescence-An In Vitro Study.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
28 10 2022
Historique:
received: 15 09 2022
revised: 19 10 2022
accepted: 26 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 15 11 2022
Statut: epublish

Résumé

Cobalamin (vitamin B12) deficiency is one of the major factors causing degenerative changes in the nervous system and, thus, various neurological and psychiatric symptoms. The underlying cellular mechanism of this phenomenon is not yet fully understood. An accumulation of senescent astrocytes has been shown to contribute to a wide range of pathologies of the nervous system, including neurodegenerative disorders. This study aimed to investigate whether cobalamin deficiency triggers astrosenescence. After inducing cobalamin deficiency in normal human astrocytes in vitro, we examined biomarkers of cellular senescence: SA-β-gal, p16

Identifiants

pubmed: 36359805
pii: cells11213408
doi: 10.3390/cells11213408
pmc: PMC9655094
pii:
doi:

Substances chimiques

Vitamin B 12 P6YC3EG204
Cyclin-Dependent Kinase Inhibitor p16 0
Cyclin-Dependent Kinase Inhibitor p21 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Nutrients. 2013 Nov 15;5(11):4521-39
pubmed: 24248213
Cell Mol Life Sci. 2021 Dec;78(23):7757-7776
pubmed: 34714358
Nat Rev Neurosci. 2006 Mar;7(3):194-206
pubmed: 16495941
Front Aging Neurosci. 2021 Feb 25;13:646924
pubmed: 33732142
Aging Cell. 2019 Jun;18(3):e12937
pubmed: 30815970
Cancer Res. 1995 Jun 1;55(11):2284-92
pubmed: 7757977
Trends Mol Med. 2019 Sep;25(9):750-759
pubmed: 31122805
J Biol Chem. 2022 Oct;298(10):102405
pubmed: 35988650
Clin Med (Lond). 2015 Apr;15(2):145-50
pubmed: 25824066
Mayo Clin Proc Innov Qual Outcomes. 2019 May 27;3(2):200-214
pubmed: 31193945
Nat Rev Dis Primers. 2017 Jun 29;3:17040
pubmed: 28660890
Bio Protoc. 2022 Jul 05;12(13):
pubmed: 35937931
Cancer Res. 2010 Nov 15;70(22):9381-90
pubmed: 21062974
Cell. 2019 Oct 31;179(4):813-827
pubmed: 31675495
Int J Mol Sci. 2020 Sep 21;21(18):
pubmed: 32967177
Biol Chem. 2019 Aug 27;400(9):1113-1127
pubmed: 31188740
Am J Clin Nutr. 2007 Nov;86(5):1384-91
pubmed: 17991650
Neurosci Lett. 2017 Jan 1;636:190-195
pubmed: 27840145
Exp Gerontol. 2004 Nov-Dec;39(11-12):1713-21
pubmed: 15582287
Biomolecules. 2022 Jan 14;12(1):
pubmed: 35053277
PLoS One. 2012;7(9):e45069
pubmed: 22984612
Neuropathol Appl Neurobiol. 2020 Feb;46(2):171-185
pubmed: 31077599
Cells. 2020 Oct 09;9(10):
pubmed: 33050187
Cell Mol Life Sci. 2011 Mar;68(6):1021-31
pubmed: 21116678
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2603-2611
pubmed: 30683717
Front Pharmacol. 2019 Sep 27;10:1114
pubmed: 31611796
PLoS One. 2016 Jan 22;11(1):e0146797
pubmed: 26799654
Mol Cell Biol. 2001 Mar;21(5):1552-64
pubmed: 11238892
Acta Diabetol. 2015 Apr;52(2):383-93
pubmed: 25315630
Int J Clin Exp Pathol. 2020 Jul 01;13(7):1829-1833
pubmed: 32782711
Mech Ageing Dev. 2002 Mar 31;123(6):613-25
pubmed: 11850025
Cells. 2019 Nov 24;8(12):
pubmed: 31771278
Nat Rev Nephrol. 2022 Oct;18(10):611-627
pubmed: 35922662
Am Fam Physician. 2017 Sep 15;96(6):384-389
pubmed: 28925645
Lancet Neurol. 2020 Mar;19(3):255-265
pubmed: 31813850
Nat Rev Drug Discov. 2022 May;21(5):339-358
pubmed: 35173313
Exp Cell Res. 2010 Oct 15;316(17):2961-8
pubmed: 20620137
Int J Mol Sci. 2018 Sep 19;19(9):
pubmed: 30235895
J Am Geriatr Soc. 2017 Oct;65(10):2297-2301
pubmed: 28869295
EMBO Rep. 2014 Nov;15(11):1139-53
pubmed: 25312810
Front Pharmacol. 2022 Aug 26;13:896907
pubmed: 36091769
Mov Disord. 2018 May;33(5):762-770
pubmed: 29508904

Auteurs

Zuzanna Rzepka (Z)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland.

Jakub Rok (J)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland.

Justyna Kowalska (J)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland.

Klaudia Banach (K)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland.

Dorota Wrześniok (D)

Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiellońska Str., 41-200 Sosnowiec, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH